1. Nano-matrixes propped self-enhanced electrochemiluminescence biosensor for microRNA detection.
- Author
-
Sun, Weijia, Zhang, Nuo, Ren, Xiang, Wu, Dan, Jia, Yue, Wei, Qin, and Ju, Huangxian
- Subjects
- *
ELECTROCHEMILUMINESCENCE , *BIOSENSORS , *ELECTRON emission , *LUMINOPHORES , *MESOPOROUS silica , *INTRAMOLECULAR proton transfer reactions , *RUTHENIUM compounds - Abstract
MicroRNAs (miRNA) are the potential biomarker for breast cancer, a biosensor for detecting miRNA-21 was successfully prepared by covalently linking carbohydrazide (CON 4 H 6) and tris (4,4 ′- dicarboxylic acid-2,2' - bipyridyl) ruthenium dichloride (Ru (dcbpy) 3 2+) as a self-enhanced emitter (Ru–CON 4 H 6). The biosensor was prepared by coating the electrode with mesoporous silica encapsulated Ru–CON 4 H 6 as luminophores (RMSNs) to covalently link a couple of DNA strands (Q1-H2). The RMSNs coated electrode exhibited strong ECL emission due to the intramolecular electron transfer between the electrochemically oxidized Ru (dcbpy) 3 2+ and co-reactant CON 4 H 6. In the presence of target miRNA-21 and an assistant hairpin H1, H2 could be released from the surface through a strand displacement reaction (SDR), and the reserved Q1 could form G-quadruplex upon the addition of K+. The formed G-quadruplex then interacted with Q2-Fc in the presence of Mg2+ to form a DNA complex on the biosensor surface, which quenched the nano-matrixes propped self-enhanced ECL emission through the electron exchange between Fc and electrode or oxidized ECL intermediates. Under optimal conditions, the ECL decrease showed a correlation with target concentration, leading to a biosensing method for sensitive detection of miRNA-21. The proposed ECL method demonstrated a detectable concentration range from 0.1 fM to 1 nM along with a detection limit of 0.03 fM, good accuracy, and acceptable reproducibility, showing that the self-enhanced ECL biosensing strategy supported by nano-matrix provided a new way for the ultrasensitive detection of miRNA, and promoted the development of breast cancer diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF